
A 2-year randomised, double-blind, placebo-controlled, multicentre study of oral selective iNOS inhibitor, cindunistat (SD-6010), in patients with symptomatic osteoarthritis of the knee
Hellio le Graverand, M.-P., Clemmer, R. S., Redifer, P., Brunell, R. M., Hayes, C. W., Brandt, K. D., Abramson, S. B., Manning, P. T., Miller, C. G., Vignon, E.Volume:
72
Langue:
english
Journal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2012-202239
Date:
February, 2013
Fichier:
PDF, 352 KB
english, 2013